| Column Group Iii Gp, Lp |
Non-Executive |
Surrozen, Inc./DE (SRZN)
|
2025-11-13 |
$12.65 |
0.0% |
315,457
|
$3,990,531 |
| Column Group Iii Gp, Lp |
Non-Executive |
Surrozen, Inc./DE (SRZN)
|
2025-03-26 |
$11.60 |
0.0% |
1,034,482
|
$11,999,991 |
| Column Group Iii Gp, Lp |
Non-Executive |
Tenaya Therapeutics, Inc. (TNYA)
|
2025-03-05 |
$0.70 |
0.0% |
35,714,284
|
$24,999,999 |
| Column Group Iii Gp, Lp |
Non-Executive |
Surrozen, Inc./DE (SRZN)
|
2024-04-04 |
$15.50 |
-37.2% |
193,548
|
$2,999,994 |
| Column Group Iii Gp, Lp |
Non-Executive |
Tenaya Therapeutics, Inc. (TNYA)
|
2024-02-12 |
$4.50 |
-46.2% |
2,222,222
|
$9,999,999 |
| Column Group Iii Gp, Lp |
Non-Executive |
Tenaya Therapeutics, Inc. (TNYA)
|
2023-03-10 |
$2.60 |
-6.8% |
6,779
|
$17,596 |
| Column Group Iii Gp, Lp |
Non-Executive |
Tenaya Therapeutics, Inc. (TNYA)
|
2023-02-08 |
$2.60 |
-6.9% |
1,500,000
|
$3,900,000 |
| Column Group Iii Gp, Lp |
Non-Executive |
Tenaya Therapeutics, Inc. (TNYA)
|
2023-01-19 |
$2.50 |
-3.1% |
69,739
|
$174,201 |
| Column Group Iii Gp, Lp |
Non-Executive |
Tenaya Therapeutics, Inc. (TNYA)
|
2023-01-18 |
$2.51 |
-3.6% |
185,151
|
$464,827 |
| Column Group Iii Gp, Lp |
Non-Executive |
Tenaya Therapeutics, Inc. (TNYA)
|
2022-11-21 |
$2.60 |
-6.9% |
9,615,384
|
$24,999,998 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
-9.3% |
$-7,763,593 |
$83,547,136 |